top of page
Search

Diabetes Insipidus (Cranial vs Nephrogenic)

TL;DR

Endo: Diabetes Insipidus (Cranial vs. Nephrogenic) is a high-yield MRCP Part 1 topic centred on polyuria, polydipsia, and ADH physiology. The key to scoring is distinguishing central (ADH deficiency) from nephrogenic (renal resistance) using the water deprivation test and desmopressin response. Focus on causes such as lithium, interpretation of urine osmolality, and targeted management strategies.


Why this matters

In MRCP Part 1, endocrine questions frequently test physiology translated into clinical reasoning. Diabetes Insipidus (DI) is a classic example—simple in concept but commonly misunderstood in exam settings. Candidates must rapidly differentiate cranial from nephrogenic DI, often using minimal data such as sodium levels and urine osmolality trends.

This topic also integrates pharmacology (e.g. lithium), renal physiology, and imaging—making it a favourite for single-best-answer questions.

For a broader preparation strategy, refer to the MRCP Part 1 overview.


Core sections

1. Definition and Pathophysiology

Diabetes Insipidus is characterised by:

  • Excessive production of dilute urine

  • Increased thirst (polydipsia)

  • Impaired water reabsorption in the kidneys

Cranial (central) DI

  • Due to reduced secretion of ADH from the posterior pituitary

Nephrogenic DI

  • Due to renal insensitivity to ADH despite normal or elevated levels

Key concept: ADH acts on V2 receptors in the collecting ducts → promotes water reabsorption. Failure at any point leads to dilute urine and increased plasma osmolality.

2. Causes (Frequently Tested)

Cranial DI

  • Idiopathic (most common in exams)

  • Head trauma or neurosurgery

  • Pituitary or hypothalamic tumours (e.g. craniopharyngioma)

  • CNS infections (e.g. meningitis)

Nephrogenic DI

  • Lithium therapy (most tested cause)

  • Hypercalcaemia

  • Hypokalaemia

  • Chronic kidney disease

  • Genetic mutations (V2 receptor defects)

👉 NICE overview of electrolyte disorders:https://cks.nice.org.uk/topics/hypernatraemia/

3. Clinical Features

  • Polyuria (>3 L/day)

  • Polydipsia (often for cold water)

  • Nocturia

  • Hypernatraemia (if water intake inadequate)

Exam clue: Altered mental status + hypernatraemia → suspect DI with impaired thirst mechanism.

4. Diagnostic Approach (High-Yield Table)

Feature

Cranial DI

Nephrogenic DI

ADH levels

Low

Normal/High

Urine osmolality (baseline)

Low

Low

After water deprivation

Low

Low

After desmopressin

↑ Significant rise

No significant change

Key exam rule:

  • Response to desmopressin → cranial DI

  • No response → nephrogenic DI

5. Investigations

  • Serum sodium: Elevated

  • Plasma osmolality: High

  • Urine osmolality: Low (<300 mOsm/kg)

  • MRI brain: To evaluate pituitary in cranial DI

6. Management Principles

Cranial DI

  • Desmopressin (DDAVP)

  • Treat underlying cause

Nephrogenic DI

  • Stop offending drugs (e.g. lithium)

  • Thiazide diuretics

  • Low-salt diet

  • NSAIDs (reduce urine output)

7. High-Yield Summary Points (Exam Gold)

  1. DI = polyuria + dilute urine + hyperosmolar plasma

  2. Cranial DI = ADH deficiency

  3. Nephrogenic DI = ADH resistance

  4. Lithium is the classic cause of nephrogenic DI

  5. Water deprivation test differentiates DI from primary polydipsia

  6. Desmopressin response distinguishes cranial vs nephrogenic DI

  7. Hypercalcaemia can cause nephrogenic DI

  8. MRI is required in suspected cranial DI

  9. Thiazides paradoxically reduce urine output

  10. Always interpret sodium with osmolality


Practical examples / mini-cases

MCQ Example

A 50-year-old patient on lithium presents with excessive urination and thirst. Investigations show:

  • Serum sodium: 151 mmol/L

  • Urine osmolality: low


    After desmopressin, urine osmolality remains unchanged.

Diagnosis: Nephrogenic Diabetes Insipidus

Explanation: Lithium induces renal resistance to ADH. Lack of response to desmopressin confirms nephrogenic DI.

👉 Practise similar questions here:

MRCP Part 1 endocrine revision notes on diabetes insipidus study setup

Common pitfalls (5 bullets)

  • Confusing primary polydipsia with DI

  • Forgetting lithium as a key cause

  • Misinterpreting desmopressin response

  • Ignoring serum sodium levels

  • Assuming all DI responds to desmopressin


FAQs

1. What is the main difference between cranial and nephrogenic DI?

Cranial DI involves reduced ADH secretion, whereas nephrogenic DI is due to renal resistance to ADH.

2. How is the water deprivation test used?

It assesses urine concentration ability. Desmopressin is then used to differentiate between cranial and nephrogenic DI.

3. Why are thiazides used in nephrogenic DI?

They reduce urine output by increasing proximal sodium and water reabsorption.

4. Which drug commonly causes nephrogenic DI?

Lithium is the most commonly tested cause.

5. When is MRI indicated?

In suspected cranial DI to evaluate pituitary or hypothalamic pathology.


Ready to start?

Integrate this topic into your broader revision using the MRCP Part 1 overview. Reinforce concepts with active recall via the Free MRCP MCQs and test readiness using Start a mock test.

For related topics, pair this with SIADH and electrolyte disorders for contrast-based understanding.


Sources

 
 
 

Comments

bottom of page